Gritstone Oncology, Inc. IPO Research Information

Gritstone Oncology, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Gritstone Oncology, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Gritstone Oncology, Inc.	GRTS - NASDAQ	$13.00-$15.00	$15.00	$15.20	6.7 million	9/28/2018
Underwriter(s): Goldman Sachs, Cowen, Barclays
Co-Manager(s): BTIG
Industry: Health Care
Filing(s): Filed 2018-08-23 Terms Added 2018-09-17

Gritstone Oncology, Inc. Quote & Chart - Click for current quote - GRTS

About Gritstone Oncology, Inc. (adapted from Gritstone Oncology, Inc. prospectus):
They are an immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "GRTS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.